A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (From the ATOLL Trial)

Study Questions:

In a per-protocol analysis of the ATOLL (Acute Myocardial Infarction Treated With Primary Angioplasty and Intravenous Enoxaparin or Unfractionated Heparin to Lower Ischemic and Bleeding Events at Short- and Long-Term Follow-Up) trial, what are outcomes of enoxaparin compared to unfractionated heparin (UFH)?